Drug Trial Radar · NCT01732822
A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease
Last checked: Nov 20, 2026Latest source record: Oct 30, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
13,885
Actual
Start
Dec 4, 2012
Primary completion
Sep 26, 2016
Study completion Sep 26, 2016
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Nov 26, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- Who can join
- All sexes, from 50 years, up to 130 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.
Conditions
- Peripheral Artery Disease
Interventions
TicagrelorDrug
Ticagrelor 90 mg bd (and Clopidogrel placebo od) taken orally as tablets
ClopidogrelDrug
Clopidogrel 75 mg od (and Ticagrelor placebo bd) taken orally as tablets
Primary outcomes
What the sponsor says the trial is designed to measure.
- Composite of Cardiovascular (CV) Death/MI/Ischemic StrokeTime frame: From randomization to PACD, an average of 2.5 years
Locations
776 sites in 28 countries. Site status is shown where the registry gives one.
Research Site
Alexander City, Alabama
Research Site
Auburn, Alabama
Research Site
Birmingham, Alabama
Research Site
Birmingham, Alabama
Research Site
Mobile, Alabama
Research Site
Mobile, Alabama
Research Site
Mobile, Alabama
Research Site
Cottonwood, Arizona
Research Site
Mesa, Arizona
Research Site
Phoenix, Arizona
Research Site
Phoenix, Arizona
Research Site
Scottsdale, Arizona
Research Site
Fort Smith, Arkansas
Research Site
Jonesboro, Arkansas
Research Site
Little Rock, Arkansas
Research Site
Anaheim, California
Research Site
Berkeley, California
Research Site
Beverly Hills, California
Research Site
Chula Vista, California
Research Site
El Cajon, California
Research Site
Fresno, California
Research Site
La Jolla, California
Research Site
La Mesa, California
Research Site
Laguna Hills, California
Research Site
Long Beach, California
Research Site
Mission Viejo, California
Research Site
Moreno Valley, California
Research Site
Northridge, California
Research Site
Oceanside, California
Research Site
Orange, California
Research Site
Palo Alto, California
Research Site
Sacramento, California
Research Site
Sacramento, California
Research Site
San Diego, California
Research Site
San Diego, California
Research Site
San Francisco, California
Research Site
Stockton, California
Research Site
Torrance, California
Research Site
Torrance, California
Research Site
Loveland, Colorado
Showing 40 of 776 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.